Common Contracts
2 similar At Market Issuance Sales Agreement contracts
Prospectus Supplement (To Prospectus dated May 15, 2018)At Market Issuance Sales Agreement • February 4th, 2021 • New York
We have entered into an At Market Issuance Sales Agreement, dated August 5, 2016, with B. Riley Securities, Inc. (formerly known as B. Riley FBR, Inc.) or B. Riley, as amended by amendment no. 1, dated May 7, 2018, to the At Market Issuance Sales Agreement (as so amended, the “sales agreement”) relating to the sale of shares of our common stock offered by this prospectus supplement and the accompanying base prospectus. In accordance with the terms of the sales agreement, under this prospectus supplement and accompanying base prospectus we may offer and sell shares of our common stock, having an aggregate offering price of up to $3,258,344 from time to time through or directly to B. Riley, acting as sales agent or principal. As of the date of this prospectus supplement, we have sold an aggregate of 32,574,188 shares of our common stock (on a post 2018 split basis) having an aggregate offering price of $30,348,066 under the sales agreement with B. Riley.
Prospectus Supplement (To Prospectus dated May 15, 2018)At Market Issuance Sales Agreement • January 19th, 2021 • New York
We have entered into an At Market Issuance Sales Agreement, dated August 5, 2016, with B. Riley Securities, Inc. (formerly known as B. Riley FBR, Inc.) or B. Riley, as amended by amendment no. 1, dated May 7, 2018, to the At Market Issuance Sales Agreement (as so amended, the “sales agreement”) relating to the sale of shares of our common stock offered by this prospectus supplement and the accompanying base prospectus. In accordance with the terms of the sales agreement, under this prospectus supplement and accompanying base prospectus we may offer and sell shares of our common stock, having an aggregate offering price of up to $5,569,097 from time to time through or directly to B. Riley, acting as sales agent or principal. As of the date of this prospectus supplement, we have sold an aggregate of 12,802,366 shares of our common stock (on a post 2018 split basis) having an aggregate offering price of $15,942,452 under the sales agreement with B. Riley.
